CDMRP Peer Reviewed Cancer Research Program: Translational Team Science Award

The Translational Team Science Award (TTSA) supports hypothesis-driven translational studies. Proposal should include 2-3 PIs (At least 1 military or VA investigator is encouraged to be included as an equal partner in the research) collaborating on one of the required FY23 RCRP topic Areas listed below:

• Bladder cancer

• Blood cancers

• Brain cancer

• Colorectal cancer

• Endometrial cancer

• Esophageal cancer

• Germ cell cancers

• Head and Neck cancer

• Liver cancer

• Lymphoma

• Mesothelioma

• Metastatic cancers

• Myeloma

• Neuroblastoma

• Pediatric, adolescent, and young adult cancers

• Pediatric brain tumors

• Stomach cancer

• Sarcoma

• Thyroid cancer

• Von Hippel-Lindau syndrome malignancies (excluding cancers of the kidney and pancreas)

Applications must also address at least one of the FY23 PRCRP Military Relevance Focus Areas:

• Environmental/exposure risk factors associated with cancer
• Mission readiness and gaps in cancer research that may affect

It is expected that nine (9) awards will be granted. 

Funding: $2,500,000 total
Duration: 4 years

Research Authority due date: 18.6.23

Pre application (required) due date: 25.7.23
Full application due date: 10.8.23